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SUMMARY 
“Slow co-production”, achieved by involving patients in in-depth 
research, can help deepen patient involvement in healthcare. 
Using our participatory qualitative research project This Sickle 
Cell Life as a case study, we describe how slow co-production 
offers a specific and mutually beneficial form of patient and public 
involvement and engagement (PPI/E). As well as generating in-
depth qualitative data for researchers, slow co-production can 
generate high-quality patient-centred knowledge to inform 
service improvement and to allow examination and reflection on 
the co-production processes and relationships themselves. All of 
these outcomes can deliver benefits for patients, their parents 
and carers, and health services. 
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ABSTRACT 
Background  
Co-production and co-design are increasingly popular 
terms in healthcare, policymaking and research. During 
these processes, essential, patient-centered knowledge can 
be co-produced. 
 
Aims 
We discuss how ‘slow co-production’ is an under-used but 
valuable tool for co-production in healthcare design.  
 
Method 
We present our research project This Sickle Cell Life as a 
case study. This is an ongoing qualitative exploration of 
healthcare transitions for young people with sickle cell 
disease. The research is co-produced with affected young 
people, their parents and carers, and other stakeholders. 
 
Conclusion 
Slow co-production, practised by involving patients in our 
qualitative, in-depth research from the start and 
throughout the project, can deepen patient involvement 
processes within healthcare. Slow co-production reveals 
the nuances of the specific setting and context of health 
experiences, and develops transferable patient-centred 
knowledge that can be applied elsewhere. This powerful 
technique is currently underused. 
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BACKGROUND 
‘Co-production’ and ‘co-design’ are increasingly popular 
terms in healthcare, policymaking, and research. We have 
previously defined co-production as an ‘exploratory space 
that brings together different values and social relations’ 
(Filipe et al. p2)1 and co-production can generate 
meaningful ways of shaping and taking part in health 
care.2 3 It has a central role in NHS service reform in the 
United Kingdom, with the revised mission statement of 
the health service emphasising ‘patient-centred’ care.45 
Similarly, co-design is defined by the NHS as a form of 
‘shared decision making’,6 providing a way to realise the 
‘full potential’ of patients in healthcare settings, with the 
aim of making ‘patient centred services a reality’ (Robert 
et al. p1).7 What co-producing knowledge in the context 
of patient and public involvement means in reality, 
however, is less certain; this paper offers an insight into 
how it might be practised. 
 
Healthcare service planning is often based on survey data 
and supposition about what the target group needs, 
rather than in-depth understanding of the wider factors 
influencing health and health behaviours.8 Further, 
patients, particularly children and young people, are 
often ‘only given a passive role with staff making all the 
decisions’ in terms of how to improve services,9 and 
meaningful involvement at earlier stages such as study 
design is even less embedded. Where top-down planning 
models dominate and where there is a strong emphasis 
on quantitative data – the situation in most healthcare 
service delivery settings – there is little scope for patient 
voices or patient participation in service planning or 
priority setting. Children and young people may be 
particularly excluded, and we focus on their needs here 
because of our work with this group. 
 
We propose a ‘slow co-production’ approach to help 
address this problem. We see slow co-production as a 
process of in-depth qualitative research that involves the 
patient from the earliest planning stages such as project 
proposal development and funding applications, through 
data gathering and analysis, to practical and policy 
outcomes. It is not typical at present to consider this type 
of qualitative research as a way of practising co-design, 
                                                 
1 At the same time, we recognise the importance of attending 
to the ways in which the ‘slow’ approach might be gendered 
and classed (Mendick, H. Social class, gender and the pace of 
and we would argue that this should change. Borrowing 
from the terminology of the ‘slow science’ movement,1 a 
‘slow co-production’ approach helps emphasise 
participatory thinking and practice10 and generates 
knowledge that is deeper and more responsive to the 
wider social context and the changing temporalities of 
children’s and young people’s health and lives. This 
knowledge can in turn help researchers and clinicians to 
design child and youth-centred health services and health 
promotion strategies, progressing a valuable form of 
human-centred design.11 A slow co-production approach 
can develop more sustained and personalised 
engagements, as well as improving understanding of how 
children and young people experience healthcare over 
time. From this deeper engagement, such an approach 
can involve children and young people in dynamic 
processes that go beyond shallow or ‘lip service’ 
involvement. 
 
In previous research, we have examined some of the 
differences between tokenistic involvement and more 
valuable forms of co-production.12 13 14 15 16. The notion 
of co-production of value and services in health care 
‘cannot be dissociated from the values and implications 
of co-producing knowledge or the meanings of 
participation as a social and political process’ (Felipe et al. 
p2).17 We examined what co-production actually means 
and what exactly it is that is being coproduced.18 Here we 
build on that work in order to attend specifically to the 
new forms of knowledge that emerge out of co-productive 
processes through ‘slow’, in-depth participatory 
qualitative research with young people with a long-term 
health condition. The different dimensions within this 
knowledge – embodied, affective, and experiential – 
contrast to the traditional large-scale, solely quantitative 
survey knowledge more often used in researching health 
conditions. In this research project, it is health related 
knowledge that is being co-produced. To illustrate this 
point, we will discuss a specific case study of This Sickle 
Cell Life – a slow co-production project in which we 
explore young people’s experiences of living with sickle 
cell disease and of transitioning from child to adult health 
services.  
 
academic life: What kind of solution is slow? Forum: 
Qualitative Social Research. 2014; 15(3), 7. http://nbn-
resolving.de/urn:nbn:de:0114-fqs140374).  
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METHOD 
We use as a case study our UK-based, NIHR-funded, 
patient co-designed project This Sickle Cell Life to illustrate 
how slow co-production is being built into our work with 
young people. There is little research on how social 
context mediates transitions between children’s and adult 
healthcare services for sickle cell. This lack of information 
hinders delivery of quality healthcare for young people. 
This Sickle Cell Life aims to increase knowledge around the 
‘neglected area’19 of transition care by conducting an in-
depth examination of young people’s experiences of 
moving from child to adult services. The project explores 
the experiences of 13-21 year-olds with sickle cell disease 
as they transition from child to adult NHS services, taking 
a holistic approach in order to examine how these 
experiences are integrated into their whole lives beyond 
the clinical setting. 
 
This Sickle Cell Life was conceptualised and designed with 
the patients and patient representatives we encountered 
during an investigation into patient involvement in sickle 
cell disease healthcare improvement, part of our work 
with the NIHR Collaboration for Leadership in Applied 
Health Research and Care (CLAHRC) for North-west 
London. We collaboratively designed This Sickle Cell Life 
with people with sickle cell and their carers from the 
earliest proposal and planning stages. 48 young people in 
London and Birmingham participated in the research. 
The study was approved by the appropriate LSHTM and 
NHS research ethics committees, participant transcripts 
were anonymised and we provided young people involved 
in the study with information on referral agencies should 
they need help with issues raised in interview. Our in-
depth qualitative research includes repeated interviews 
(80 in total) and participant diaries (completed between 
interviews) with young people with sickle cell, to facilitate 
prolonged, contextual and more personalised 
engagements with participants. We also interviewed 
healthcare providers across participants’ paediatric, 
transitional and adult services. During this process of co-
producing knowledge via in-depth qualitative research, 
patient and carer representatives continued to 
participate, from helping to design research tools, to 
analysing and interpreting findings. We are working with 
them and with other stakeholders (patient charities, 
clinicians, service improvement experts) to co-produc 
support resources based on our study findings. 
 
RESULTS 
Our work on This Sickle Cell Life shows how co-
production can support and shape qualitative research. 
Co-producing research ‘slowly’ allowed conceptual space 
for deeper reflection and analysis, as well as time to build 
the relationships necessary to engage patients in 
knowledge co-production. Taking time to analyse the 
different elements of the interview account, such as 
reported speech or participant non-verbal behaviours, has 
helped us to generate broader observations about the 
social processes, contexts, and relationships that underlie 
people’s accounts. Conducting in-depth interviews on 
young people’s ‘home turf’ and adopting an open 
approach that allowed them to elaborate on issues that 
were important to them, has also produced highly 
contextualised insights with all the additional depth that 
this allows us to capture. Repeated interviews helped us 
capture changes over time, including deeper insights into 
the fluctuating nature of their condition. 
 
Our ‘slow’ co-production involved more than just 
qualitative interviewing. Interpreting findings, 
dissemination and non-academic outcomes of this project 
are all processes that are collaboratively co-produced with 
stakeholders. Patients and patient representatives actively 
participate in This Sickle Cell Life in deciding how best to 
translate and communicate co-produced knowledge into 
resources for service improvement. The co-production 
model has the advantage of producing detailed findings 
that help amplify the concerns of patients themselves by 
involving them both as active research participants and as 
patient representatives within the patient and public 
involvement (PPI) environments that are becoming more 
popular in healthcare settings. In the process we ‘create 
knowledge in ways that differ from currently valued 
modes of research’ which tend to favour ‘information 
acquisition’ over ‘knowledge production’ (Adams et al. 
p194).20 We do this not only by prioritising in-depth 
approaches to understand patient experience, but by 
involving healthcare users and carers as research partners 
in thinking about service improvement. Certainly, the 
longer timeframe involved and the specialist expertise 
required in a ‘slow’ approach is useful in amplifying 
young people’s voices, and in recognising young people 
as experts in their own conditions, bodies and lives. 
 
Slow co-production can bring challenges, particularly 
because it is not always compatible with traditional 
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academic research and funding models, with their 
emphasis on metrics and the standard academic outputs 
required within the university system. 21 22 For instance, 
research funding deadlines caused problems for us by 
disrupting the patient involvement process at the grant 
proposal stage – turnaround times to respond to reviewer 
comments were too short for us to ensure all parties had 
a say and our deadline extension request was refused. 
Some relationships may not be fully established at the 
time the research funding is sought, and so key scoping 
work can become compressed. Flexibility in our approach 
was important for us to engage in successful co-
production. For instance, regular meetings were not 
always possible to organise with all stakeholders at once. 
We replaced them with other spaces for dialogue that 
better responded to participants' needs and preferences, 
such as smaller meetings or alternative activities. 
Activities involving both researchers and non-researcher 
participants must meet the needs and preferences of both 
parties; in this project, workshop days or informal 
collaborative discussions such as coffee shop meetings 
with different stakeholders proved helpful in sharing 
ideas and shaping the direction of the research. 
Reflecting on our own roles in the research process and 
how they shape our work has helped us critique our own 
assumptions as well as larger conventional epistemologies 
in healthcare research.23  
 
DISCUSSION 
In This Sickle Cell Life, we do not conceptualise healthcare 
transition as a purely clinical experience; rather, we see 
healthcare transitions as a set of evolving processes. We  
situate these processes within patients’ broader social 
context and their whole lives, including for instance their 
experiences of education and relationships. The co-
produced knowledge resulting from the in-depth and 
long-term engagement with patients captures the 
temporalities of sickle cell2 and of larger health 
transitions. In doing so, this project is well positioned to 
inform and improve care pathways into adult services. 
 
Slow co-production as we conceptualise it here is of 
course more onerous than some of the more established 
methodologies for co-production such as workshops, 
which may be quicker but likely lack depth. The nature 
                                                 
2 For example, sickle cell disease is marked by fluctuating 
pain. At one point a patient may feel healthy and report a 
of in-depth, one-on-one interviews means that using these 
methodologies can be time-consuming and expensive. In-
depth research also requires specialists, as well as 
responsiveness to participants’ needs and preferences. 
High quality research interviews require a higher level of 
training and selection than for survey questionnaires 
where the interviewer can simply read the questions to 
the respondent. A qualitative interview requires the 
interviewer to know the topic area, to be able to elicit rich 
narratives on difficult topics, and ask clarification 
questions in appropriate ways should interviewees seem 
to contradict themselves or make vague statements. 
Participants might prefer to be interviewed in their 
homes and local communities, which also increases the 
time needed for data collection. All these considerations 
require time, resources, and reflection from researchers 
and participants alike. 
 
In fact, the time consuming and highly complex nature 
of in-depth qualitative analysis on work that includes 
such a rich range of co-produced data is what allows slow 
co-production to lead to high-quality outputs. As Adams 
et al. (2014: 180) argue,24 slow science is not about ‘doing 
less over time’, but about ‘working with an ethic or set of 
values and strategies that valorise different things from 
the emergent norms’. Descriptive qualitative studies yield 
simple reports of interviews or focus group discussions 
but may not have wider relevance, whereas the slow co-
production we are experimenting with helps capture 
details of the wider context of health experiences, and 
how these interact with services and experiences of 
healthcare. 
 
Further, a slow co-production approach recognises that 
patient involvement can be messy. There are complex 
power dynamics at play25 26 that must be recognised and 
navigated, such as who is in charge of budgets, who is 
ultimately answerable to the funder, and who drives the 
dissemination of co-produced knowledge. Involving 
patient and carer representatives as collaborators also 
required resources to support their time on the project. 
We had specifically requested these costs from the funder 
in our grant proposal for the study, and were fortunate 
that our funder supported us in this endeavour.  
 
wellness narrative in interview, but in a later interview the 
may narrate a recent sickle cell crisis. 
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It is important to illuminate co-production ‘messiness’ 
and encourage continuous reflection throughout the co-
production process to help improve understanding of 
how a co-production approach can be implemented and 
improved. 
 
CONCLUSION 
 
In-depth, qualitative research offers one way to improve 
participatory approaches in healthcare research; slow co-
production can help amplify patient voice and centre 
patient experience. We would argue that co-production 
of knowledge related to healthcare (for example about 
experiences of using services and living with a chronic 
condition, in this scenario sickle cell disease) should be 
viewed as a key aspect of service co-design. This form of 
co-design improves understanding of local health 
contexts and the temporalities of health experiences, and 
generates patient-centred knowledge for healthcare 
improvement. It also helps us to capture the specificities 
of the wider social context of patients’ health experiences, 
and how this wider context affects (and is affected by) 
healthcare service provision and uptake. While we can 
capture the nuance of a specific setting, the depth of the 
analysis in this approach helps yield findings that are 
transferrable to other contexts – in the case of This Sickle 
Cell Life, for instance, it helps build wider knowledge 
about transitions between child and adult care, relevant 
to sickle cell but also to other health conditions. 
 
To achieve the highest level of co-production and co-
designed work with patients, sufficient resources and 
time must be allocated to allow in-depth participatory 
processes to develop, including through dedicated 
qualitative research. A slow co-production approach 
allows time, place and pace for quality relationships to 
develop, enhancing dialogue between researcher and 
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